The patient with C-ANCA/PR3-ANCA-positive crescentic pauci-immune glomerulonephritis and recurrence of nephritic sediment

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 2084-2087

  Andrassy, Martin ^a   Sis, Jeanne ^a   Waldherr, Rüdiger ^a   Zeier, Martin ^a   Schwenger, Vedat ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Anti glomerular basement membrane (GBM) antibodies; Anti neutrophil cytoplasmatic antibodies (ANCA); Glomerulonephritis (GN); Goodpasture's disease

Indexed keywords

AZATHIOPRINE; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTON PUMP INHIBITOR;

ADD ON THERAPY; ADULT; ANAMNESIS; ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; ARTICLE; CASE REPORT; CHOLESTASIS; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTRITIS; GASTROINTESTINAL SYMPTOM; GLOMERULONEPHRITIS; HEMATEMESIS; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY TEST; LONG TERM CARE; LOW DRUG DOSE; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SEROLOGY; UNSPECIFIED SIDE EFFECT; URINALYSIS;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY, NEEDLE; COMPLEMENT C3 NEPHRITIC FACTOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOHISTOCHEMISTRY; METHYLPREDNISOLONE; MIDDLE AGED; RECURRENCE; RISK ASSESSMENT; TREATMENT OUTCOME; URINALYSIS;

EID: 44449133842     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn092     Document Type: Article

References (19)

1. Jayne DRW, Marshall PD, Jones SJ et al. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990; 37: 965-970
2. Weber MFA, Andrassy K, Pullig O et al. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol 1992; 2: 1227-1234
3. Verburgh CA, Bruijn JA, Daha MR et al. Sequential development of anti-GBM nephritis and ANCA-associated pauci-immune glomerulonephritis. Am J Kidney Dis 1999; 34: 344-348
4. Hagen EC, Daha MR, Hermans J et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998; 53: 743-753
5. Short AK, Esnault VLM, Lockwood CM. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis 1995; 26: 439-445
6. Levy JB, Hammad T, Coulthard A et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004; 66: 1535-1540
7. Donoghue DJ, Short CD, Brenchley PE et al. Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease. Clin Nephrol 1989; 32: 251-255
8. Bosch X, Mirapeix E, Font J et al. Prognostic implication of antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 1991; 36: 107-113
9. Yang G, Tang Z, Chen Y et al. Antineutrophil cytoplasmic antibodies in Chinese patients with anti-GBM crescentic glomerulonephritis. Clin Nephrol 2005; 63: 423-428
10. Johnson JP, Moore J, Austin HA et al. Therapy of antiglomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 1985; 64: 219-227
11. Turner N, Rees A. Antiglomerular basement membrane disease. In: Cameron S, Davison AM, Grünfeld JP et al. (eds). Oxford Textbook of Clinical Nephrology, Vol. 1. Oxford: Oxford University Press, 1992, 438-452
12. Klassen J, Elwood C, Grossberg AL et al. Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis. N Engl J Med 1974; 290: 1340-1344
13. Huey B, McCormick K, Capper J et al. Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotide probe hybridization. Kidney Int 1993; 44: 307-312
14. Neary P, Kadlubowski M, Thomson D et al. Antiglomerular basement membrane disease with C-ANCA positivity without pulmonary involvement. Nephrol Dial Transplant 1996; 11: 693-695
15. Kalluri R, Meyers K, Mogyorosi A et al. Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol 1997; 8: 1795-1800
16. Vanhille P, Noel LH, Reumaux D et al. Late emergence of systemic vasculitis with anti-neutrophil cytoplasmic antibodies in a dialysed patient with anti-glomerular basement membrane glomerulonephritis. Clin Nephrol 1990; 33: 257-258
17. Peces R, Rodriguez M, Pobes A et al. Sequential development of pulmonary hemorrhage with MPO-ANCA complicating anti-glomerular basement membrane antibody-mediated glomerulonephritis. Am J Kidney Dis 2000; 35: 954-957
18. Serratrice J, Chiche L, Dussol B et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 2004; 43: E14
19. Andrassy K, Waldherr R, Erb A et al. De novo glomerulonephritis in patients during remission from Wegener's granulomatosis. Clin Nephrol 1992; 38: 295-298